EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations

Noah K Taylor, Matthew J Guggenbiller, Pranali P Mistry, Oliver D King, Scott Q Harper

Molecular Therapy - Methods & Clinical Development · 2024-09 · 32 (3) · 101295

DOI: 10.1016/j.omtm.2024.101295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy - Methods & Clinical Development, 2024-09. Verfasst von Noah K Taylor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43215, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIAMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AAVAAV biologyAAV cross-packagingAAV transfer plasmidCTCFadeno-associated virusinsulatorsinverted terminal repeatvector engineering

Autor:innen und Institutionen

  • Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43215, USA.
  • Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
  • Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

Förderung

  • NIAMS NIH HHS
  • NIAMS

Zitieren

APA

Taylor, N. K., Guggenbiller, M. J., Mistry, P. P., King, O. D., & Harper, S. Q. (2024). A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations. Molecular Therapy - Methods & Clinical Development, 32(3), 101295. https://doi.org/10.1016/j.omtm.2024.101295

Vancouver

Taylor NK, Guggenbiller MJ, Mistry PP, King OD, Harper SQ. A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations. Molecular Therapy - Methods & Clinical Development. 2024;32(3):101295. doi:10.1016/j.omtm.2024.101295

BibTeX
@article{Taylor2024,
  author = {Taylor, Noah K and Guggenbiller, Matthew J and Mistry, Pranali P and King, Oliver D and Harper, Scott Q},
  title = {A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations},
  journal = {Molecular Therapy - Methods & Clinical Development},
  year = {2024},
  volume = {32},
  number = {3},
  pages = {101295},
  doi = {10.1016/j.omtm.2024.101295}
}
Kostenlos starten →